Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi Center, Randomized, Double Blind, Placebo-controlled, Dose Escalation Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ACZ885 Administered Intravenously to Patients With Type 2 Diabetes Mellitus

NCT00605475 is registered in ClinicalTrials.gov with Novartis as lead sponsor.

NCT NCT00605475
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00605475 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi Center, Randomized, Double Blind, Placebo-controlled, Dose Escalation Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ACZ885 Administered Intravenously to Patients With Type 2 Diabetes Mellitus
Lead sponsor
Novartis
Phase
Phase 2
Overall status
Completed
Start date
December 31, 2007
Completion date
September 30, 2010
Enrollment
231 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

type 2 diabetes mellitus